Loading...
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
INTRODUCTION: Infliximab, an antibody against tumor necrosis factor alpha, is used to treat inflammatory bowel disease and has well-established efficacy and proven safety. Complications of this treatment are related to immunosuppression and include higher risk of serious infections and malignant neo...
Na minha lista:
| Udgivet i: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627392/ https://ncbi.nlm.nih.gov/pubmed/26518665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-015-0730-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|